We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Tempus AI Inc (TEM) USD0.0001 A

Sell:$59.32 Buy:$59.45 Change: $1.47 (2.54%)
NASDAQ:1.13%
Market closed |  Prices as at close on 30 August 2024 | Switch to live prices |
Sell:$59.32
Buy:$59.45
Change: $1.47 (2.54%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 30 August 2024 | Switch to live prices |
Sell:$59.32
Buy:$59.45
Change: $1.47 (2.54%)
Market closed |  Prices as at close on 30 August 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Tempus AI, Inc. is a technology company. The Company provides next generation diagnostics across multiple disease areas, with technology capabilities, harnessing the data and analytics to help personalize medicine. The Company’s product lines include genomics, data, and artificial intelligence applications (AI). Its genomics product line leverages its laboratories to provide next generation sequencing, diagnostics, polymerase chain reaction (PCR), profiling, molecular genotyping, and other anatomic and molecular pathology testing. The Company's AI applications are focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools. Its primary product of AI applications is Next, an AI platform that leverages machine learning to apply an intelligent layer onto routinely generated data to proactively identify and minimize care gaps for oncology and cardiology patients.

Contact details

Address:
600 West Chicago Avenue, Suite 510
CHICAGO
60654
United States
Telephone:
+ ()
Website:
https://www.tempus.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
TEM
ISIN:
US88023B1035
Market cap:
$9.14 billion
Shares in issue:
154.32 million
Sector:
Life Sciences Tools & Services
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Eric Lefkofsky
    Chief Executive Officer, Director
  • James Rogers
    Chief Financial Officer
  • Ryan Fukushima
    Chief Operating Officer
  • Erik Phelps
    Executive Vice President, Chief Administrative and Legal Officer, Assistant Secretary
  • Andrew Polovin
    Executive Vice President, General Counsel

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.